Market Overview

Why Fortress Biotech's Stock Is Trading Higher Today

Why Fortress Biotech's Stock Is Trading Higher Today

Fortress Biotech (NASDAQ: FBIO) shares are trading higher on Friday after the company announced positive topline clinical efficacy results for CUTX-101 Copper Histidinate in the treatment of Menkes disease.

Fortress Biotech is a biopharmaceutical company. The firm is involved in the business of acquiring, developing and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group function through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

Fortress Biotech's stock traded up 16.48% at $3.86 per share at the time of publication on Friday. The stock has a 52-week high of $4.02 and a 52-week low of $1.04.


Related Articles (FBIO)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at